Recent Division Publications

Recent Nuclear Medicine Publications

Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non-Small Cell Lung Cancer.
K. Horn, H. Thomas, H. Vesselle, et al. - Published 2021 - CLINICAL NUCLEAR MEDICINE

Performance Characteristics of a Dual-Sided Position-Sensitive Sparse-Sensor Detector for Gamma-ray Imaging
W. Hunter, Donald D. Witt, R. Miyaoka - Published 2021

Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma
K. Labadie, A. Ludwig, A. Lehnert, et al. - Published 2021 - SCIENTIFIC REPORTS

Prognostic value and peripheral immunologic correlates of early FDG PET response imaging in a phase II trial of risk-adaptive chemoradiation for unresectable non-small cell lung cancer
S. Bowen, D. Hippe, H. Thomas, et al. - Published 2021 - MEDRXIV

A Phase I Trial of First-in-Human Alpha-Emitter Astatine-211-Labeled Anti-CD45 Antibody (211At-BC8-B10) in Combination with Fludarabine and TBI As Conditioning for Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome
B. Sandmaier, D. Wilbur, D. Hamlin, et al. - Published 2021

18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study
Perrin E. Romine, Lanell M Peterson, B. Kurland, et al. - Published 2021 - BREAST CANCER RESEARCH : BCR

Clinical Impact of FDG PET/CT of the Lower Extremities in Patients With Merkel Cell Carcinoma With Primary Disease Site Outside of the Lower Extremities.
M. Ishiyama, F. Behnia, H. Vesselle - Published 2021 - AJR. AMERICAN JOURNAL OF ROENTGENOLOGY

A Path to Qualification of PET/MR Scanners for Multicenter Brain Imaging Studies: Evaluation of MR-based Attenuation Correction Methods Using a Patient Phantom.
C. Catana, R. Laforest, Hongyu An, et al. - Published 2021 - JOURNAL OF NUCLEAR MEDICINE : OFFICIAL PUBLICATION, SOCIETY OF NUCLEAR MEDICINE

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
R. Lynch, R. Cassaday, Stephen D Smith, et al. - Published 2021 - THE LANCET. HAEMATOLOGY

Use of 18F-fluciclovine PET/CT (FluPET) for prostate cancer (PC): Initial results from a prospective registry at a tertiary academic center.
R. Wong, Heather H Cheng, S. Holt, et al. - Published 2021

How Accurately does PSMA Inhibitor 18F-DCFPyL-PET-CT Image Prostate Cancer?
L. True, Delphine L. Chen - Published 2021 - CLINICAL CANCER RESEARCH

Selective Imaging of Lung Macrophages Using [11C]PBR28-Based Positron Emission Tomography
Delphine L. Chen, E. Agapov, Kangyun Wu, et al. - Published 2021 - MOLECULAR IMAGING AND BIOLOGY

Abstract PD6-10: 18F-fluoroestradiol (fes) and 18f-fluorodeoxyglucose (fdg) pet imaging in metastatic lobular breast cancer
Poorni M. Manohar, L. Peterson, V. Wu, et al. - Published 2021